Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV001252981 | SCV001428468 | likely pathogenic | Tuberous sclerosis 2 | 2019-01-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001252981 | SCV002241301 | pathogenic | Tuberous sclerosis 2 | 2021-03-02 | criteria provided, single submitter | clinical testing | This variant has been observed in individual(s) with clinical features of tuberous sclerosis complex (PMID: 26540169). ClinVar contains an entry for this variant (Variation ID: 49580). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Gln883*) in the TSC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). This variant is not present in population databases (ExAC no frequency). |
Gene |
RCV002255124 | SCV002526567 | pathogenic | not provided | 2022-06-15 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Truncating variants in this gene are considered pathogenic by a well-established clinical consortium and/or database; This variant is associated with the following publications: (PMID: 24271014, 31160751, 32017698, 26540169) |
Tuberous sclerosis database |
RCV000042841 | SCV000066637 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |